[DOI] [PubMed] [Google Scholar] Jomova K, Makova M, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Rhodes CJ, Valko M
Clinical studies with repeated dosing of ezutromid displayed promising 24-week data, with a statistically significant reduction in muscle fibre damage and increased levels of utrophin, providing the first evidence of target engagement and proof of mechanism
Verminderte Fettverwertung: L-Carnitinmangel kann die Fhigkeit der Mutter beeintrchtigen, Fett als Energiequelle zu nutzen, was zu einer bermigen Abhngigkeit von Glukose fhren kann
48 In addition, adiponectin promotes inflammatory cell apoptosis by suppressing NF-B- and tumor necrosis factor (TNF)--induced expression of anti-apoptotic Bcl-2 (which contains NF-B-binding sites in its promoter region), as well as inhibiting p50 DNA binding and p65 transactivation subunits